TILCIK 1789769

Instil Bio, Inc.

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2025

10-K filed 2026-03-27

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies TIL discloses as major customers, as a share of TIL revenue. 1 active, 0 lapsed.

Company	% of TIL revenue	Est. revenue	Period	Trend	Status	Source
AstraZeneca Pharmaceuticals LP Non-SEC AstraZeneca Pharmaceuticals LP	Named	—	FY 2025-12-31	—	Active	10-K 2026-03-27
The Tarzana facility is currently leased to AstraZeneca Pharmaceuticals LP (“Tenant”) and Tenant has a right of first offer to purchase it. 10-K filed 2026-03-27 Period FY 2025-01-01 to 2025-12-31Accession 0001789769-26-000019

Alerts are coming

Get an email when TIL's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.